Phathom Pharmaceuticals
Stock Forecast, Prediction & Price Target
Phathom Pharmaceuticals Financial Estimates
Phathom Pharmaceuticals Revenue Estimates
Phathom Pharmaceuticals EBITDA Estimates
Phathom Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $682K 0% | Avg: $163.65M Low: $143.84M High: $201.55M avg. 23896.92% | Avg: $356.34M Low: $288.65M High: $463.19M avg. 117.73% | Avg: $513.43M Low: $415.90M High: $667.38M avg. 44.08% | Avg: $707.15M Low: $572.82M High: $919.19M avg. 37.72% |
Net Income
% change YoY
| $-148.09M N/A | $-223.00M -50.58% | $-201.59M 9.60% | Avg: $-266.12M Low: $-219.51M High: $-151.30M avg. -32.01% | Avg: $-139.79M Low: $-153.86M High: $24.61M avg. 47.47% | Avg: $-11.66M Low: $-16.21M High: $-8.78M avg. 91.65% | Avg: $76.29M Low: $57.45M High: $106.03M avg. 753.84% |
EBITDA
% change YoY
| $-137.09M N/A | $-170.41M -24.30% | $-159.04M 6.67% | Avg: $98.19M Low: $86.30M High: $120.93M avg. 161.73% | Avg: $213.80M Low: $173.19M High: $277.91M avg. 117.73% | Avg: $308.06M Low: $249.54M High: $400.43M avg. 44.08% | Avg: $424.29M Low: $343.69M High: $551.51M avg. 37.72% |
EPS
% change YoY
| -$4 N/A | -$5.7 -42.50% | -$3.93 31.05% | Avg: -$3.8 Low: -$4.28 High: -$2.95 avg. 3.35% | Avg: -$1.71 Low: -$3 High: $0.48 avg. 55.03% | Avg: -$0.23 Low: -$0.32 High: -$0.17 avg. 86.68% | Avg: $1.49 Low: $1.12 High: $2.07 avg. 753.84% |
Operating Expenses
% change YoY
| $135.08M N/A | $172.44M 27.65% | $167.82M -2.67% | Avg: $5.79B Low: $5.08B High: $7.13B avg. 3350.42% | Avg: $12.60B Low: $10.21B High: $16.38B avg. 117.73% | Avg: $18.16B Low: $14.71B High: $23.61B avg. 44.08% | Avg: $25.02B Low: $20.26B High: $32.52B avg. 37.72% |
FAQ
What is Phathom Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 215.23% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -219.51M, average is -266.12M and high is -151.30M.
What is Phathom Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 6024.11% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $143.84M, average is $163.65M and high is $201.55M.
What is Phathom Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 224.72% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$4.28, average is -$3.8 and high is $-2.95.
What is the best performing analyst?
In the last twelve months analysts have been covering Phathom Pharmaceuticals stock. The most successful analyst is Annabel Samimy.